Acuvue contact lenses: daily comfort for US eyes

Acuvue contact lenses from Johnson & Johnson Vision are a major soft contact lens brand in US eye care, offering daily and reusable options for nearsightedness, farsightedness, and astigmatism with a focus on comfort and UV blocking.

Acuvue contact lenses are soft contact lenses developed by Johnson & Johnson Vision and are among the most widely prescribed brands in the US soft lens market, according to the company and US trade coverage (Johnson & Johnson Vision, 04/2024; Review of Contact Lenses, 06/2023).

Updated: 05/17/2026 | Reading time: approx. 10 minutes

By the AD HOC NEWS editorial team - specialized in product-led market coverage.

At a Glance

• Product: Acuvue contact lenses
• Category: Soft contact lenses
• Brand/Manufacturer: Johnson & Johnson Vision
• Main Use Cases: Vision correction for refractive errors
• Availability: Prescription lenses via eye care professionals
• Key Markets: United States and global eye care markets

What Acuvue contact lenses Is and How It Works

Acuvue contact lenses are soft, disposable lenses that rest on the tear film covering the cornea to correct refractive errors such as myopia, hyperopia, astigmatism, and presbyopia (Johnson & Johnson Vision, 04/2024).

These lenses are made from hydrogel or silicone hydrogel materials that allow oxygen to pass through to the cornea, which supports corneal health when worn as directed by an eye care professional (Contact Lens Spectrum, 01/2024).

Acuvue products include daily disposable options and lenses for longer replacement intervals, each designed to be worn for a specified period and then replaced according to a prescribed schedule (Johnson & Johnson Vision, 04/2024).

Why Acuvue contact lenses Matters for Consumers and Industry

For US consumers, Acuvue contact lenses provide an alternative to eyeglasses, which can be helpful for sports, outdoor activities, and users seeking a wider field of view than spectacles typically provide (American Academy of Ophthalmology, 09/2023).

Many Acuvue lenses incorporate UV blocking to help shield parts of the eye from ultraviolet radiation, although sunglasses are still recommended for full eye protection (Acuvue US, 03/2024).

The Acuvue family offers specific designs for astigmatism and presbyopia, supporting individualized correction and fitting by eye care professionals in optometry and ophthalmology practices (Johnson & Johnson Vision, 04/2024).

Acuvue contact lenses in the US and Global Market

In the United States, soft contact lenses such as Acuvue are dispensed as prescription medical devices regulated by the US Food and Drug Administration, and lenses must be fitted and prescribed by licensed eye care professionals (FDA, 02/2024).

Acuvue lenses are widely distributed through US optometrists, ophthalmologists, and authorized retailers, and Johnson & Johnson Vision positions the brand as a core part of its global vision care portfolio (Johnson & Johnson, 10/2023).

Internationally, Acuvue products are sold in multiple regions, with formulations adapted to local regulatory requirements and prescription practices in different markets (Johnson & Johnson Vision, 04/2024).

• Soft disposable lenses in daily and reusable formats
• Options for myopia, hyperopia, astigmatism, presbyopia
• Prescription-only medical devices in the US
• Hydrogel and silicone hydrogel materials
• UV-blocking features on selected models

Frequently Asked Questions About Acuvue contact lenses

Are Acuvue contact lenses approved in the US?
Yes, Acuvue soft contact lenses are regulated as prescription medical devices in the United States and must meet FDA requirements for safety and effectiveness (FDA, 02/2024).

Do Acuvue contact lenses replace UV-protection sunglasses?
Acuvue lenses with UV-blocking materials help reduce UV exposure to covered areas of the eye but are not a substitute for UV-protective sunglasses, which are still recommended for full protection (Acuvue US, 03/2024).

How do I get Acuvue contact lenses in the US?
US consumers need a valid contact lens prescription from a licensed eye care professional, who can then determine if Acuvue options are suitable and arrange supply through their office or authorized channels (FDA, 02/2024).

Acuvue contact lenses are produced by Johnson & Johnson Vision, a business of Johnson & Johnson that focuses on ophthalmic products, surgical systems, and vision care.

Johnson & Johnson shares are listed on the NYSE under the ticker JNJ, and the issuer ISIN is US4781601046, which identifies the company in international securities clearing systems.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.